KBC Group NV (OTCMKTS:KBCSY – Get Free Report) saw a large drop in short interest in the month of January. As of January 15th, there was short interest totalling 5,600 shares, a drop of 79.1% from the December 31st total of 26,800 shares. Based on an average trading volume of 70,400 shares, the short-interest ratio is presently 0.1 days.
KBC Group Stock Performance
Shares of OTCMKTS KBCSY traded down $0.01 during midday trading on Thursday, reaching $39.10. 118,447 shares of the company traded hands, compared to its average volume of 63,723. KBC Group has a 12 month low of $30.13 and a 12 month high of $40.32. The stock’s 50-day simple moving average is $37.71 and its 200-day simple moving average is $37.67. The firm has a market cap of $32.65 billion, a PE ratio of 10.05, a PEG ratio of 1.55 and a beta of 1.12.
KBC Group (OTCMKTS:KBCSY – Get Free Report) last posted its quarterly earnings data on Thursday, November 7th. The company reported $1.18 earnings per share for the quarter. The company had revenue of $6.92 billion during the quarter. KBC Group had a net margin of 11.36% and a return on equity of 12.49%. On average, equities research analysts expect that KBC Group will post 4.43 EPS for the current year.
About KBC Group
KBC Group NV, together with its subsidiaries, provides integrated bank-insurance services primarily for retail, private banking, small and medium sized enterprises, and mid-cap clients. The company offers demand deposits and savings accounts; home and mortgage loans; consumer finance and SME funding services; credit, investment fund and asset management, and life and non-life insurance; and cash management, payments, trade finance, lease, money market, capital market products, and stockbroking services.
Read More
- Five stocks we like better than KBC Group
- Low PE Growth Stocks: Unlocking Investment Opportunities
- Microsoft Stock Breaks Trend, But It Doesn’t Matter—Here’s Why
- How to Short Nasdaq: An Easy-to-Follow Guide
- How Value Investors Find Undervalued Stocks and Build Wealth
- 3 Stocks to Consider Buying in October
- Is Tonix Pharmaceuticals the Next Biotech Breakout?
Receive News & Ratings for KBC Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for KBC Group and related companies with MarketBeat.com's FREE daily email newsletter.